Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular adrenocortical tumourigenesis.

M Reincke1, F Beuschlein, M Slawik

  • 1Division of Endocrinology, Medical Department II, University of Freiburg, Germany.

European Journal of Clinical Investigation
|April 3, 2001
PubMed
Summary

Adrenocortical neoplasms, often found incidentally, vary in origin. Adrenocortical carcinomas are monoclonal, while adenomas can be polyclonal, with distinct genetic pathways influencing their development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancer.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025
Same author

Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients-current status and DEGRO recommendations.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025
Same author

Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE).

Pituitary·2024
Same author

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers.

Pituitary·2023
Same author

One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology.

European journal of endocrinology·2021

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Adrenocortical neoplasms are common adrenal cortex abnormalities, frequently detected incidentally ('incidentalomas').
  • Adrenocortical carcinoma is a rare, highly malignant tumor, while adenomas are more common.
  • Advances in understanding adrenocortical tumorigenesis involve identifying genes in hereditary adrenal tumors.

Purpose of the Study:

  • To investigate the genetic and clonal differences between adrenocortical adenomas and carcinomas.
  • To explore the role of specific genes and signaling pathways in adrenocortical tumor development.
  • To differentiate the molecular mechanisms underlying adrenocortical tumors from other endocrine neoplasms.

Main Methods:

  • Analysis of clonal composition in adrenal tumors (monoclonal vs. polyclonal).

Related Experiment Videos

  • Identification of key genes and mutations in adrenocortical carcinomas (e.g., p53, IGF II).
  • Investigation of the ACTH receptor gene in various adrenocortical lesions.

    • Main Results:

    • Adrenocortical carcinomas are monoclonal; adenomas can be polyclonal (25-40%).
    • Mutations in p53 and IGF II hyperexpression are implicated in adrenocortical carcinomas.
    • ACTH receptor gene deletions are found in aggressive carcinomas and undifferentiated adenomas, unlike other endocrine tumors.

    Conclusions:

    • Adrenocortical tumorigenesis involves distinct genetic alterations and signaling pathways compared to other endocrine tumors.
    • Clonal heterogeneity differentiates carcinomas from adenomas.
    • ACTH receptor gene deletions may play a role in aggressive adrenocortical neoplasms.